Skip to main content

Dr. Patterson successfully defended her PhD thesis, “Understand and Optimizing Chemotherapy Combinations,” under the guidance of Dr. Adam Palmer, on May 31.

Dr. Sarah Cooper Patterson with mentor Dr. Adam Palmer after her PhD defense.
Dr. Sarah Cooper Patterson with PhD mentor, Dr. Adam Palmer

Dr. Patterson will be moving on to a position with the United States Patent and Trademark Office as a Patent Examiner.  We wish you all the best, Sarah!


Add links to pubmed or bioRxiv

Patterson SC, Pomeroy AE, and Palmer AC. “Ultrasensitive response explains the benefit of combination chemotherapy despite drug antagonism.” AACR Molecular Cancer Therapeutics, 2024 Mar 26. doi: 10.1158/1535-7163.MCT-23-0642. Online ahead of print. PMID: 38530117.

Hwangbo H, Patterson SC, Dai A, Plana D, Palmer AC. “Additivity predicts the efficacy of most approved combination therapies for advanced cancer.” Nature Cancer, 2023 Dec;4(12):1693-1704. doi: 10.1038/s43018-023-00667-z. Epub 2023 Nov 16. PMID: 37974028.

Patterson SC, Palmer AC. “Predicting in vivo activity of combination therapies from in vitro drug pairs in diverse environments.” Cell Rep Med. 2022 Sep 20;3(9):100745. doi: 10.1016/j.xcrm.2022.100745. PMID: 36130481; PMCID: PMC9512690.

Dr. Patterson also has another paper currently in review with a peer-reviewed journal.

Another pic of Sarah at her PhD party.  Click for larger view.

Dr. Sarah Cooper Patterson at her PhD defense celebration.
Sarah at her PhD defense celebration!